Ashley Hill, FNP-BC

Ashley Hill, FNP-BC

Nurse Practitioner, Hypertension Specialist
Internal Medicine
Accepting new patients
Call for an appointment
217-545-8000
or
Request appointment
Language:
English

    About me

    Gender

    Female

    Education & training

    Positions
    Adult Nurse Practitioner
    Cardiology, Department of Internal Medicine
    Undergraduate Degree
    Walden University, Chamberlain College Of Nursing
    Lincoln Land Community College

    Clinical trials

    Trial
    Internal Medicine

    AstraZeneca BaxPA: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Baxdrostat in Adult Participants with Primary Aldosteronism

    Active recruiting

    The purpose of this clinical trial is to learn more about a new, investigational, once daily medication, called baxdrostat, and its ability to lower blood pressure in individuals diagnosed with primary aldosteronism.

    Eligible patients include those who currently have a diagnosis of high blood pressure, specifically primary aldosteronism, despite having taken or are currently taking anti-hypertensive medications.

    Contact: Katy Martz 217-545-4342
    Trial
    Internal Medicine

    THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System vs. Sham for the Adjunctive Treatment of Hypertension

    Active recruiting

    The purpose of this clinical trial is to assess whether a medical device called the TIVUS System can lower high blood pressure in patients who are known to have hypertension. 

    Eligible patients include those who currently have a diagnosis of high blood pressure despite having taken or currently taking anti-hypertensive medications.

    Contact: Katy Martz 217-545-4342
    Trial
    Internal Medicine

    Radiance US GPS: The Global Paradise® System US Post Approval Study

    Active recruiting

    The purpose of this clinical study is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication.

    Eligible patients include those who currently have a diagnosis of high blood pressure despite having taken or are currently taking anti-hypertensive medications.

    Contact: Katy Martz 217-545-4342
    Trial
    Internal Medicine

    Mineralys MLS-101-301 A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL ARM, MULTICENTER PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LORUNDROSTAT IN SUBJECTS WITH UNCONTROLLED AND RESISTANT HYPERTENSION

    Active not recruiting

    The purpose of this clinical trial is to assess the blood pressure lowering effects of lorundrostat, taken once daily, in patients with high blood pressure.

    Contact: Emily Starkey 217-545-7616
    Trial
    Internal Medicine

    AstraZeneca BaxHTN: A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypert

    Active not recruiting

    The purpose of this clinical trial is to trial is to learn more about a new, investigational, once daily medication, called baxdrostat, and its ability to lower blood pressure in individuals not responding to their current treatment.

    Contact: Katy Martz 217-545-4342
    Trial
    Internal Medicine

    Mineralys (MLS-101-202): A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL ARM, MULTI-CENTER, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LORUNDROSTAT IN SUBJECTS WITH UNCONTROLLED HYPERTENSION ON A STANDARDIZED MEDICATION REGIMEN

    Active not recruiting

    The purpose of this clinical trial is to assess the blood pressure lowering effects of lorundrostat, taken once daily, in patients with high blood pressure.

    Contact: Emily Starkey 217-545-7511
    Trial
    Internal Medicine

    RADIANCE Continued Access Protocol (CAP): A study of the ReCor Medical Paradise System in Clinical Hypertension

    Active not recruiting
    The purpose of this clinical trial is to find out if a medical device called the Paradise Renal Denervation System can lower blood pressure in patients who have hypertension.
    Contact: Katy Martz 217-545-4342
    Trial
    Internal Medicine

    The "RADIANCE II" Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

    Active not recruiting
    The purpose of this clinical study is to see whether a medical device called the Paradise Renal Denervation System (also called The Paradise System) can lower high blood pressure in patients who are known to have hypertension.
    Contact: Katy Martz 217-545-4342